Article
Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board.
Targeted oncology - 1 Mar 2023
Dorman Klara, Zhang Danmei, Heinrich Kathrin, Reeh Laurens, Weiss Lena, Haas Michael, Beyer Georg, Rössler Daniel, Goni Elisabetta, Renz Bernhard W, D'Haese Jan G, Kunz Wolfgang G, Seidensticker Max, Corradini Stefanie, Niyazi Maximilian, Ormanns Steffen, Kumbrink Jörg, Jung Andreas, Klauschen Frederick, Werner Jens, Mayerle Julia, von Bergwelt-Baildon Michael, Boeck Stefan, Heinemann Volker, Westphalen C Benedikt
Abstract excerpt
BACKGROUND: In pancreatic cancer, systemic treatment options in addition to chemotherapy remain scarce, and so far only a small proportion of patients benefit from targeted therapies. OBJECTIVE: The patients with pancreatic cancer discussed in the CCCMunichLMU Molecular Tumor Board were reviewed to gain a better real-world understanding of the challenges and chances of precision oncology in this hard-to-treat...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.